Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial

Published:2019-09 Issue:3 Volume:144 Page:738-749
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Sharif Hanisah,Singh Iesha,Kouser Lubna,Mösges Ralph,Bonny Marie-Alix,Karamani Angeliki,Parkin Rebecca V.,Bovy Nicolas,Kishore Uday,Robb Abigail,Katotomichelakis Michael,Holtappels Gabriële,Derycke Lara,Corazza Francis,von Frenckell Rémy,Wathelet Nathalie,Duchateau Jean,Legon Thierry,Pirotton Sabine,Durham Stephen R.,Bachert Claus,Shamji Mohamed H.

Funder

ASIT Biotech S.A.

Institute of Medical Statistics, Informatics and Epidemiology

Biotech tools

ALK-Abelló

Anergis

Adiga

Biomay

Allergy Therapeutics

Med Update GmbH

Food Standards Agency

National Institute for Health Research

Ghent University Hospital

ASIT Biotech S.A

Immune Tolerance Network

Regeneron

Merck

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper;Bousquet;J Allergy Clin Immunol,1998

2. Recombinant allergens: what does the future hold?;Valenta;J Allergy Clin Immunol,2011

3. Long-term clinical efficacy of grass-pollen immunotherapy;Durham;N Engl J Med,1999

4. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies;James;J Allergy Clin Immunol,2011

5. Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: the GRASS randomized clinical trial;Scadding;JAMA,2017

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory B Cells—Immunopathological and Prognostic Potential in Humans;Cells;2024-02-18

2. Mechanisms and Predictive Biomarkers of Allergen Immunotherapy in the Clinic;The Journal of Allergy and Clinical Immunology: In Practice;2024-01

3. Immunological mechanisms of tolerance: Central, peripheral and the role of T and B cells;Asia Pacific Allergy;2023-12

4. T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy;Heliyon;2023-11

5. Leptin favors imbalance of antigen-specific CD4+ T-cells associated with severity of cat allergy;Frontiers in Immunology;2023-10-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3